Suppr超能文献

在年轻成年人中,α-和β-肾上腺素能受体阻断对肾上腺素能药物诱发的前臂出汗以及热环境中运动诱发的前臂出汗的单独和联合作用。

Separate and combined blockades of α- and β-adrenergic receptors in forearm sweating induced by adrenergic agents and exercise in the heat in young adults.

作者信息

Amano Tatsuro, Fujii Naoto, Kenny Glen P, Mündel Toby, Inoue Yoshimitsu, Yokoyama Shotaro, Kondo Narihiko

机构信息

Laboratory for Exercise and Environmental Physiology, Faculty of Education, Niigata University, Niigata, Japan.

Institute of Health and Sport Sciences, University of Tsukuba, Tsukuba City, Japan.

出版信息

Am J Physiol Regul Integr Comp Physiol. 2025 Feb 1;328(2):R181-R194. doi: 10.1152/ajpregu.00120.2024. Epub 2024 Dec 20.

Abstract

The assessment of adrenergic modulation of sweating as assessed via pharmacologic administration of α- and β-adrenergic receptor blockers during exercise has yielded mixed findings. However, the underlying mechanisms for this disparity remain unresolved. We investigated the effects of separate and combined blockade of α- and β-adrenergic receptors on forearm sweating induced by a 30-min moderate-intensity exercise bout ( = 17, ) and the administration of adrenergic agonists epinephrine and norepinephrine ( = 16, ) in the heat. Adrenergic receptor blockade was induced via the separate and combined iontophoretic administration of terazosin (α-adrenergic receptor antagonist) and propranolol (β-adrenergic receptor antagonist) on forearm skin. Bretylium, a noradrenergic sympathetic nerve inhibitor, was also administered separately in . In , relative to the separate administration of propranolol, terazosin alone or in combination with propranolol attenuated exercise sweating to a similar extent (both ≤ 0.037), although the effect was reduced relative to that observed with bretylium treatment ( < 0.001). In , administration of propranolol increased norepinephrine- ( = 0.029) but not epinephrine-induced sweat rate. The combined administration of terazosin reversed this response, attenuating sweating ( < 0.001) to a greater extent than terazosin treatment alone ( = 0.030). Altogether, we showed that although β-adrenergic receptors may interact with α-adrenergic receptors pharmacologically, it does not appear to modulate exercise-induced sweating on the forearm. Furthermore, α- but not β-adrenergic receptors independently modulate the regulation of forearm sweating during exercise in the heat. Finally, the bretylium-induced reduction in forearm sweat rate during exercise likely occurs independently of α- and β-adrenergic receptors. Pharmacological stimulation of α- and β-adrenergic receptors produces sweating in vivo. Still, the separate and interactive roles of these adrenergic receptors during exercise and pharmacological adrenergic stimulation in the heat remain unknown. We showed that β-adrenergic receptors may interact with α-adrenergic receptors pharmacologically, but it does not modulate exercise-induced sweating. The α-adrenergic receptors independently modulate sweating during exercise in the heat. We provide important new insights into our understanding of the mechanisms regulating human sweating.

摘要

通过在运动期间药理学给予α和β肾上腺素能受体阻滞剂来评估出汗的肾上腺素能调节,结果不一。然而,这种差异的潜在机制仍未得到解决。我们研究了单独和联合阻断α和β肾上腺素能受体对30分钟中等强度运动(n = 17)和在热环境中给予肾上腺素能激动剂肾上腺素和去甲肾上腺素(n = 16)所诱导的前臂出汗的影响。通过在前臂皮肤分别和联合离子电渗给予特拉唑嗪(α肾上腺素能受体拮抗剂)和普萘洛尔(β肾上腺素能受体拮抗剂)来诱导肾上腺素能受体阻断。在n中,还单独给予了去甲肾上腺素能交感神经抑制剂溴苄铵。在n中,相对于单独给予普萘洛尔,单独使用特拉唑嗪或与普萘洛尔联合使用在相似程度上减弱运动出汗(两者P≤0.037),尽管相对于溴苄铵治疗观察到的效果有所降低(P<0.001)。在n中,给予普萘洛尔增加了去甲肾上腺素诱导的出汗率(P = 0.029),但未增加肾上腺素诱导的出汗率。特拉唑嗪的联合给药逆转了这种反应,比单独使用特拉唑嗪治疗更显著地减弱出汗(P<0.001)(P = 0.030)。总之,我们表明,虽然β肾上腺素能受体可能在药理学上与α肾上腺素能受体相互作用,但它似乎并未调节前臂运动诱导的出汗。此外,α而非β肾上腺素能受体独立调节热环境中运动期间前臂出汗的调节。最后,溴苄铵诱导的运动期间前臂出汗率降低可能独立于α和β肾上腺素能受体发生。α和β肾上腺素能受体的药理学刺激在体内产生出汗。然而,这些肾上腺素能受体在运动和热环境中药理学肾上腺素能刺激期间的单独和相互作用作用仍然未知。我们表明,β肾上腺素能受体可能在药理学上与α肾上腺素能受体相互作用,但它不调节运动诱导的出汗。α肾上腺素能受体在热环境中运动期间独立调节出汗。我们为理解调节人体出汗的机制提供了重要的新见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验